Interactions between the endogenous cannabinoid system and the peptides of the Tyr-MIF-1 family modulate heat stress-induced analgesia

Hristina H. Nocheva; Roman E. Tashev; Adriana I. Bocheva; Dimitrinka Y. Atanasova; Angel D. Dandov; Nikolai E. Lazarov

doi:10.14748/bmr.v31.7708

Interactions between the endogenous cannabinoid system and the peptides of the Tyr-MIF-1 family modulate heat stress-induced analgesia

Hristina H. Nocheva, Roman E. Tashev, Adriana I. Bocheva, Dimitrinka Y. Atanasova, Angel D. Dandov, Nikolai E. Lazarov

Abstract

The present study aimed at evaluating whether an interaction between the endocannabinoid system (ECS) and peptides from the Tyr-MIF-1 family modulates heat stress-induced analgesia. For this purpose, adult male rats were subjected to 1 hour of heat stress. Pain perception was estimated in vivo by Paw pressure test. Immunohistochemical evaluation of CB1 receptors was also performed in the periaqueductal grey (PAG). Our results showed that the application of CB1-receptor agonist anandamide at the end of the stress led to a tendency of decrease in heat-SIA. We also found that each of the four Tyr-MIF-1 peptides interacted with the ECS after acute heat stress, resulting in changes in the PP-thresholds with different direction, degree, and duration. In particular, the administration of MIF-1 and Tyr-K-MIF-1 after CB1-receptor agonist anandamide increased heat stress-induced analgesia (heat-SIA) after the 10th min, while Tyr-MIF-1 and Tyr-W-MIF-1 produced only short-lasting analgesia. CB1-expression in the PAG was also estimated, showing an increase after Tyr-MIF-1 and Tyr-W-MIF-1 administration with anandamide pretreatment, and a decrease after Tyr-W-MIF-1 administration with the CB1-receptor antagonist AM251- or the opioid receptor antagonist naloxone pretreatment. In summary, it can be inferred that under heat stress conditions the peptides from the Tyr-MIF-1 family, interacting with opioid and non-opioid receptors, differently relate with the cannabinoid system and such an interaction modulates heat stress-induced analgesia. It also seems that Tyr-MIF-1 and Tyr-W-MIF-1 have a direct impact on CB1-expression in the PAG, while MIF-1 and Tyr-K-MIF-1 probably act via second messengers or the activation of additional neurotransmitter system(s).

Keywords

stress-induced analgesia, endocannabinoid system, Tyr-MIF-1 peptides, Paw pressure test, immunohistochemistry

Full Text

References

Gonzalez-Rivas PA, Chauhan SS, Ha M, Fegan N, Dun-shea FR, Warner RD. Effects of heat stress on animal physiology, metabolism, and meat quality: A review. Meat Science 2020;162:108025. doi: 10.1016/j.meats-ci.2019.108025.

Lupien SJ, McEwen BS, Gunnar MR, Heim C. Effects of stress through-out the lifespan on the brain, behavior and cognition. Nat Rev Neurosci 2009;10:434-445. doi: 10.1038/nrn2639.

Goldstein DS. Stress, allostatic load, catecholamines, and other neurotransmitters in neurodegenerative dis-eases. Endocr Regul 2011;45:91-98. doi: 10.1007/s10571-011-9780-4.

Amit Z, Galina ZH. Stress-induced analgesia: adaptive pain suppression. Physiol Rev 1986;66:1091-1120. doi: 10.1152/physrev.1986.66.4.1091.

Hohmann AG, Suplita RL, Bolton NM, Neely MH, Fegley D, Mangieri R, et al. An endocannabinoid mechanism for stress-induced analgesia. Nature 2005;435:1108-1112. doi: 10.1038/nature03658.

Butler RK, Fin DP. Stress-induced analgesia. Prog Neurobiol 2009;88:184-202. doi: 10.1016/j.pneuro-bio.2009.04.003.

Mechoulam R, Parker LA. The endocannabinoid system and the brain. Annu Rev Psychol 2013;64:21-47. doi: 10.1146/annurev-psych-113011-143739.

Di Marzo V, Melck D, Bisogno T, De Petrocellis L. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci 1998;21:521-528. doi: 10.1016/s0166-2236(98)01283-1.

Devane WA, Dysarz FA, Johnson MR, Melvin LS, Howlett AC. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 1988;34:605-613. PMID: 2848184.

Matsuda LA, Lolait SJ, Brownstein M, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990;346:561-564. doi: 10.1038/346561a0.

Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993;365:61-65. doi: 10.1038/365061a0.

Devane WA, Hanus L, Breuer, A., Pertwee, RG, Stevenson LA, Griffin G, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992;258:946-949. doi: 10.1126/sci-ence.1470919.

Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, et al. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 1995;215:89-97. doi:10.1006/bbrc.1995.2437.

Gong J-P, Onaivi ES, Ishiguro H, Liu Q-R, Tagliaferro PA, Brusco A, et al. Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain. Brain Res 2006;1041:10-23. doi: 10.1016/j.brainres.2005.11.035.

Svizenska I, Dubovy P, Sulcova A. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures – a short review. Pharmacol Biochem Behav 2008;90:501-511. doi:10.1016/j.pbb.2008.05.010.

Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 1991;11:563-583. doi:10.1523/JNEUROSCI.11-02-00563.1991.

Mackie K. Distribution of cannabinoid receptors in the central and peripheral nervous system. In: Cannabinoids. Handbook of Experimental Pharmacology, Pertwee RG editor. Berlin Heidelberg: Springer; 2005; 299-325. doi:10.1007/3-540-26573-2_10.

Mato S, Pazos A. Influence of age, postmortem delay and freezing storage period on cannabinoid receptor density and functionality in human brain. Neuropharmacology 2004; 46:716-726. doi:10.1016/j. neuropharm.2003.11.004.

Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1998; 83:393-411. doi:10.1016/s0306-4522(97)00436-3.

Lovinger DM. Presynaptic modulation by endocannabinoids. In: Pharmacology of Neurotransmitter Release. Handbook of Experimental Pharmacology. Berlin, Heidelberg, Springer; 2008: 435-477. doi:10.1007/978-3-540-74805-2_14.

Wilson RI, Nicoll RA. Endocannabinoid signaling in the brain. Science 2002; 296:678-682. doi:10.1126/sci-ence.1063545.

Starowicz K, Malek N, Przewlocka B. Cannabinoid receptors and pain. WIREs Membr Transp Signal 2013;2:121-132. doi:10.1002/wmts.83.

Pan W, Kastin AJ. From MIF-1 to endomorphin: The Tyr-MIF-1 family of peptides. Peptides 2007; 28:2411-2434. doi:10.1016/j.peptides.2007.10.006.

Olango WM, Roche M, Ford GK, Harhen B, Finn DP. The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nocic-petive tone. Br J Pharmacol 2012;165:2549-2560. doi: 10.1111/j.1476-5381.2011.01478.x.

Wiley JL, Walentiny MD, Wright Jr MJ, Beardsley PM, Burston JJ, Poklis JL, Lichtman AH, Vann RE. Endocan-nabinoid contribution to Δ9-tetrahydrocannabinol dis-crimination in rodents. Eur J Pharmacol 2014;737:97-105. doi:10.1016/j.ejphar.2014.05.013.

Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Academic Press 1998; San Diego.

Zadina JE, Kastin AJ, Krieg Jr EF, Coy DH. Characterization of Binding Sites for N-Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) in Rat Brain. Pharmac Biochem & Behav 1982;17:1193-1198. doi: 10.1016/0091-3057(82)90119-8.

Hackler L, Kastin AJ, Zadina JE. Isolation of a novel peptide with a unique binding profile from human brain cortex: Tyr-K-MIF-1 (Tyr-Pro-Lys-Gly-NH2). Peptides 1994;15:945-950. doi:10.1016/0196-9781(94)90056-6.

Hohmann AG, Briley EM, Herkenham M. Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord. Brain Res 1999;822:17-25. doi: 10.1016/s0006-8993(98)01321-3.

Welch SP, Stevens DL. Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine in mice. J Pharmacol Exp Ther 1992; 262:10-18. PMID: 1320680.

Salio C, Fischer J, Franzoni MF, Mackie K, Kaneko T, Conrath M. CB1-cannabinoid and mu-opioid receptor co-localization on postsynaptic target in the rat dorsal horn. Neuroreport 2001;12:3689-3692. doi: 10.1097/00001756-200112040-00017.

Nocheva H, Kochev D, Bocheva A. Effects of Tyr-MIF1 family of peptides on endocannabinoid system after im-mobilization stress. C R Acad Bulg Sci 2013;66:1051-1056. doi: 10.7546/CR-2013-66-7-13101331-18.

Nocheva H, Kochev D, Krastev D, Bocheva A. Cold stress-induced analgesia. Interactions between the TYR-MIF1 family of peptides and the endocannabinoid sys-tem. C R Acad Bulg Sci 2013;66:1639-1644.

Schlicker E, Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci 2001;22:565-572. doi:10.1016/s0165-6147(00)01805-8.

Kathmann M, Bauer U, Schlicker E, Göthert M. Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain. Naunyn Schmiedebergs Arch Pharmacol 1999;359:466-470. doi: 0.1007/PL00005377.

Nyiri G, Szabadits E, Cserep C, Mackie K, Shigemoto R, Freund TF. GABAB and CB1 cannabinoid receptor expression identifies two types of septal cholinergic neurons. Eur J Neurosci 2005; 21:3034-3042. doi:10.1111/j.1460-9568.2005.04146.x.

Häring M, Marsicano G, Lutz B, Monory K. Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice. Neuroscience 2007;146:1212-1219. doi:10.1016/j.neuroscience.2007.02.021.

Wilson-Poe AR, Morgan MM, Aicher SA, Hegarty DM. Distribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal gray. Neuroscience 2012; 213:191-200. doi:10.1016/j.neuroscience.2012.03.038.

Ferdousi M, Finn DP. Stress-induced modulation of pain: Role of the endogenous opioid system. Prog Brain Res 2018;239:121-177. doi: 10.1016/bs.pbr.2018.07.002.

Di Marzo V, De Petrocellis L. Why do cannabinoid receptors have more than one endogenous ligand? Phil Trans R Soc B 2012;367:3216-3228. doi:10.1098/rstb.2011.0382.

DOI: http://dx.doi.org/10.14748/bmr.v31.7708